Swissmedic’s technical interpretation of Annex 1
by Giuliana Miglierini New insights on the interpretation of the new Annex 1 to Good manufacturing practices (GMPs)…
How to approach drug substance supply in new product introduction (NPI) processes
by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
Key issues in technical due diligences
by Giuliana Miglierini Financial due diligence is a central theme when discussing mergers and acquisitions (M&A). Not less…